Argentina approved emergency use of China’s CanSino COVID-19 Vaccine
- Did Cloud Seeding Unleash a Deluge in Dubai?
- Scientists Identify Gut Bacteria and Metabolites that Lower Diabetes Risk
- OpenAI’s Model Matches Doctors in Assessing Eye Conditions
- UK: A Smoke-Free Generation by Banning Sales to Those Born After 2009
- Deadly Mutation: A New Monkeypox Variant Emerges in the DRC
- EPA Announces First-Ever Regulation for “Forever Chemicals” in Drinking Water
Argentina approved emergency use of China’s CanSino COVID-19 Vaccine
Argentina approved emergency use of China’s CanSino COVID-19 Vaccine. Recently, the Argentine Ministry of Health approved the emergency use of China Cansino Biotech Co., Ltd.’s COVID-19 vaccine in the country to promote a large-scale vaccination plan.
According to a Reuters report on the 12th, the Argentine Ministry of Health said that the government and China Cansino Biotech Co., Ltd. are making progress in their negotiations to purchase 5.4 million doses of vaccines.
Argentine Health Minister Bissotti said on social media that this is “good news” for Argentina, “this allows us to go one step further and continue to advance the mass vaccination plan.”
According to previous reports, in 2020, China’s Cansino Bio-COVID-19 Vaccine will carry out Phase III clinical trials in Argentina. According to the report released by the health agency that conducted the test in Argentina, the storage condition of the vaccine is 2-8 degrees Celsius, which is very conducive to storage and transportation. No volunteers participating in the test have reported adverse reactions.
In February 2021, Argentina formally approved the emergency use of the COVID-19vaccine developed by China National Pharmaceutical Group in the country. Under the advice of the Argentine Drug Administration, the Ministry of Health also decided to include the Chinese vaccine in the country’s COVID-19 vaccination plan.
At present, the COVID-19 vaccines that people can get in Argentina include the Chinese National Medicine vaccine, the Russian “Satellite-V” vaccine, and the AstraZeneca vaccine. So far, at least 12.6 million people have received one dose of vaccine and 3.2 million people have received two doses of vaccine. With the accelerating supply of vaccines, the vaccination rate has also been accelerating in recent months.
Reuters statistics show that so far, nearly 85,000 people have died of COVID-19 virus in Argentina and 4.1 million people have been diagnosed with infections.
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
